PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Inserm, Lille University Hospital Center, U1172, Lille Neuroscience & Cognition, University of Lille, Lille, France.\', \'North East Île-de-France Reference Center for Neuromuscular Diseases, FHU PHENIX, FILNEMUS, France.\', \'PACA Réunion Rhône Alpes Reference Center for Neuromuscular Diseases, FILNEMUS, France.\', \'Service of Pr Attarian, AP-HM, Marseille, France.\', \'Department of Neurology, Nancy Regional University Hospital Center, Nancy, France.\', \'Department of Neurology, Angers University Hospital Center, Angers, France.\', \'Department of Neurology, Strasbourg University Hospitals, Strasbourg, France.\', \'ENMG Service/Neuromuscular Pathologies, Lyon Civil Hospices, Lyon, France.\', \'Neurology Department, Raymond Poincaré University Hospital, Garches, Public Hospital Network of Paris, Garches, France.\', \'AOC Referral Center for Neuromuscular Diseases, Neurology and Neuromuscular Diseases Department, FILNEMUS, University Hospitals of Bordeaux, Bordeaux, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/ene.15222
?:hasPublicationType
?:journal
  • European journal of neurology
is ?:pmid of
?:pmid
?:pmid
  • 34927321
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.65
?:rankingScore_hIndex
  • 109
?:title
  • Motor and respiratory decline in patients with late onset Pompe disease after cessation of enzyme replacement therapy during COVID-19 pandemic.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all